Since the acquisition, AbbVie has used Allergan’s aesthetics and neuroscience portfolios to diversify its revenue.
: The Allergan division, now branded as Allergan Aesthetics , continues to lead the global medical aesthetics market with products like Botox. allergan stock buy or sell
: For the full year 2026, management has guided for net revenues of approximately $67 billion, representing 9.5% growth. Historical Acquisition Terms Since the acquisition
As of April 2026, . The company was acquired by AbbVie (NYSE: ABBV) in a $63 billion deal that officially closed on May 8, 2020. now branded as Allergan Aesthetics